The D3 dopamine receptor in cellular and organismal function

被引:95
作者
Shafer, RA [1 ]
Levant, B [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
关键词
limbic system; signal transduction; autoreceptor; receptor binding; behavior; locomotor activity; reward; development schizophrenia; Parkinson's disease; cocaine; antipsychotic;
D O I
10.1007/s002130050479
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The D-3 dopamine receptor is a member of the family of D-2-like dopamine receptors. Since the cloning and identification of the D-3 receptor in 1990, considerable progress has been made towards understanding the function of this novel site. Although some avenues of investigation have yielded more definitive results than others, studies to date indicate the D-3 receptor is localized preferentially in limbic brain areas and affects locomotion and perhaps reinforcement and reward. A subpopulation of the receptors appear to be autoreceptors which modulate dopamine synthesis, release, and neuronal activity. These observations have led to the hypothesis that the D-3 receptor may be an appropriate target in the treatment of neuropsychiatric disorders such as schizophrenia and drug addiction. The role of D-3 sites in disease, however, remains to be established. Genetic association of D-3 receptor polymorphisms with neuropsychiatric disorders have been proposed. Alterations in expression of Dg sites may occur in some diseases. Although the study of this receptor is clearly in the early stages, these findings lay the foundation for future investigation. In this review, dopamine D-3 receptor brain localization, cellular signaling mechanisms, and associated behavior will be discussed. The potential role of the D-3 site in neuropsychiatric disorders and as a therapeutic target is also addressed.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 201 条
  • [1] A targeted mutation of the D-3 dopamine receptor gene is associated with hyperactivity in mice
    Accili, D
    Fishburn, CS
    Drago, J
    Steiner, H
    Lachowicz, JE
    Park, BH
    Gauda, EB
    Lee, EJ
    Cool, MH
    Sibley, DR
    Gerfen, CR
    Westphal, H
    Fuchs, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) : 1945 - 1949
  • [2] BEHAVIORAL AND BIOCHEMICAL EFFECTS OF THE DOPAMINE D-3 RECEPTOR-SELECTIVE LIGAND, 7-OH-DPAT, IN THE NORMAL AND THE RESERPINE-TREATED RAT
    AHLENIUS, S
    SALMI, P
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 260 (2-3) : 177 - 181
  • [3] EFFECTS OF THE DOPAMINE D-3 RECEPTOR-LIGAND 7-OH-DPAT ON MALE-RAT EJACULATORY BEHAVIOR
    AHLENIUS, S
    LARSSON, K
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 51 (2-3) : 545 - 547
  • [4] CHARACTERIZATION OF BINDING OF [H-3]PD-128907, A SELECTIVE DOPAMINE D-3 RECEPTOR AGONIST LIGAND, TO CHO-K1 CELLS
    AKUNNE, HC
    TOWERS, P
    ELLIS, GJ
    DIJKSTRA, D
    WIKSTROM, H
    HEFFNER, TG
    WISE, LD
    PUGSLEY, TA
    [J]. LIFE SCIENCES, 1995, 57 (15) : 1401 - 1410
  • [5] EFFECTS OF DOPAMINE D-3 RECEPTOR AGONISTS ON PILOCARPINE-INDUCED LIMBIC SEIZURES IN THE RAT
    ALAM, AM
    STARR, MS
    [J]. NEUROSCIENCE, 1994, 60 (04) : 1039 - 1047
  • [6] ARETHA CW, 1995, J PHARMACOL EXP THER, V274, P609
  • [7] DOPAMINE-RECEPTOR DISTRIBUTION IN THE RAT CNS - ELUCIDATION USING ANTIPEPTIDE ANTISERA DIRECTED AGAINST D-1A AND D-3 SUBTYPES
    ARIANO, MA
    SIBLEY, DR
    [J]. BRAIN RESEARCH, 1994, 649 (1-2) : 95 - 110
  • [8] Asherson P, 1996, MOL PSYCHIATR, V1, P125
  • [9] BANCROFT GN, 1997, IN PRESS NEUROPSYCHO
  • [10] Characterization of the conditioned taste aversion produced by 7-OH-DPAT in rats
    Bevins, RA
    Delzer, TA
    Bardo, MT
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 53 (03) : 695 - 699